Found: 7
Select item for more details and to access through your institution.
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial.
- Published in:
- European Heart Journal, 2024, v. 45, n. 37, p. 3789, doi. 10.1093/eurheartj/ehae479
- By:
- Publication type:
- Article
Birth weight and heart failure: hindsight as an exact science?
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 6, p. 968, doi. 10.1093/eurjpc/zwac012
- By:
- Publication type:
- Article
Bone status in men with heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 5, p. 714, doi. 10.1002/ejhf.2794
- By:
- Publication type:
- Article
Cardiovascular and metabolic determinants of quality of life in patients with cancer.
- Published in:
- ESC Heart Failure, 2023, v. 10, n. 1, p. 167, doi. 10.1002/ehf2.14175
- By:
- Publication type:
- Article
Predictors of lower exercise capacity in patients with cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41390-0
- By:
- Publication type:
- Article
Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1062, doi. 10.3390/cells12071062
- By:
- Publication type:
- Article
Biomarkers-in-Cardiology 8 RE-VISITED—Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome—A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 2, p. 211, doi. 10.3390/cells11020211
- By:
- Publication type:
- Article